230 related articles for article (PubMed ID: 22253704)
1. Dynamic ligand modulation of EPO receptor pools, and dysregulation by polycythemia-associated EPOR alleles.
Singh S; Verma R; Pradeep A; Leu K; Mortensen RB; Young PR; Oyasu M; Schatz PJ; Green JM; Wojchowski DM
PLoS One; 2012; 7(1):e29064. PubMed ID: 22253704
[TBL] [Abstract][Full Text] [Related]
2. EPO receptor gain-of-function causes hereditary polycythemia, alters CD34 cell differentiation and increases circulating endothelial precursors.
Perrotta S; Cucciolla V; Ferraro M; Ronzoni L; Tramontano A; Rossi F; Scudieri AC; Borriello A; Roberti D; Nobili B; Cappellini MD; Oliva A; Amendola G; Migliaccio AR; Mancuso P; Martin-Padura I; Bertolini F; Yoon D; Prchal JT; Della Ragione F
PLoS One; 2010 Aug; 5(8):e12015. PubMed ID: 20700488
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin hypersensitivity in primary familial and congenital polycythemia: role of tyrosines Y285 and Y344 in erythropoietin receptor cytoplasmic domain.
Arcasoy MO; Karayal AF
Biochim Biophys Acta; 2005 Apr; 1740(1):17-28. PubMed ID: 15878737
[TBL] [Abstract][Full Text] [Related]
4. Primary familial polycythemia: a frameshift mutation in the erythropoietin receptor gene and increased sensitivity of erythroid progenitors to erythropoietin.
Sokol L; Luhovy M; Guan Y; Prchal JF; Semenza GL; Prchal JT
Blood; 1995 Jul; 86(1):15-22. PubMed ID: 7795221
[TBL] [Abstract][Full Text] [Related]
5. Increased cell surface expression of C-terminal truncated erythropoietin receptors in polycythemia.
Motohashi T; Nakamura Y; Osawa M; Hiroyama T; Iwama A; Shibuya A; Nakauchi H
Eur J Haematol; 2001 Aug; 67(2):88-93. PubMed ID: 11722595
[TBL] [Abstract][Full Text] [Related]
6. Cbl ubiquitination of p85 is essential for Epo-induced EpoR endocytosis.
Bulut GB; Sulahian R; Yao H; Huang LJ
Blood; 2013 Dec; 122(24):3964-72. PubMed ID: 24113870
[TBL] [Abstract][Full Text] [Related]
7. Two new EPO receptor mutations: truncated EPO receptors are most frequently associated with primary familial and congenital polycythemias.
Kralovics R; Indrak K; Stopka T; Berman BW; Prchal JF; Prchal JT
Blood; 1997 Sep; 90(5):2057-61. PubMed ID: 9292543
[TBL] [Abstract][Full Text] [Related]
8. Delayed hemoglobin switching and perinatal neocytolysis in mice with gain-of-function erythropoietin receptor.
Divoky V; Song J; Horvathova M; Kralova B; Votavova H; Prchal JT; Yoon D
J Mol Med (Berl); 2016 May; 94(5):597-608. PubMed ID: 26706855
[TBL] [Abstract][Full Text] [Related]
9. Absence of polycythemia in a child with a unique erythropoietin receptor mutation in a family with autosomal dominant primary polycythemia.
Kralovics R; Sokol L; Prchal JT
J Clin Invest; 1998 Jul; 102(1):124-9. PubMed ID: 9649565
[TBL] [Abstract][Full Text] [Related]
10. A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of Jak2 and Stat5 inactivation.
Arcasoy MO; Harris KW; Forget BG
Exp Hematol; 1999 Jan; 27(1):63-74. PubMed ID: 9923445
[TBL] [Abstract][Full Text] [Related]
11. Ligand-induced EpoR internalization is mediated by JAK2 and p85 and is impaired by mutations responsible for primary familial and congenital polycythemia.
Sulahian R; Cleaver O; Huang LJ
Blood; 2009 May; 113(21):5287-97. PubMed ID: 19336760
[TBL] [Abstract][Full Text] [Related]
12. Mouse model of congenital polycythemia: Homologous replacement of murine gene by mutant human erythropoietin receptor gene.
Divoky V; Liu Z; Ryan TM; Prchal JF; Townes TM; Prchal JT
Proc Natl Acad Sci U S A; 2001 Jan; 98(3):986-91. PubMed ID: 11158582
[TBL] [Abstract][Full Text] [Related]
13. JAK2 V617F stimulates proliferation of erythropoietin-dependent erythroid progenitors and delays their differentiation by activating Stat1 and other nonerythroid signaling pathways.
Shi J; Yuan B; Hu W; Lodish H
Exp Hematol; 2016 Nov; 44(11):1044-1058.e5. PubMed ID: 27473563
[TBL] [Abstract][Full Text] [Related]
14. Genetic heterogeneity of primary familial and congenital polycythemia.
Kralovics R; Prchal JT
Am J Hematol; 2001 Oct; 68(2):115-21. PubMed ID: 11559951
[TBL] [Abstract][Full Text] [Related]
15. Defining an EPOR- regulated transcriptome for primary progenitors, including Tnfr-sf13c as a novel mediator of EPO- dependent erythroblast formation.
Singh S; Dev A; Verma R; Pradeep A; Sathyanarayana P; Green JM; Narayanan A; Wojchowski DM
PLoS One; 2012; 7(7):e38530. PubMed ID: 22808010
[TBL] [Abstract][Full Text] [Related]
16. Phospho-PTM proteomic discovery of novel EPO- modulated kinases and phosphatases, including PTPN18 as a positive regulator of EPOR/JAK2 Signaling.
Held MA; Greenfest-Allen E; Su S; Stoeckert CJ; Stokes MP; Wojchowski DM
Cell Signal; 2020 May; 69():109554. PubMed ID: 32027948
[TBL] [Abstract][Full Text] [Related]
17. A novel mutation in the erythropoietin receptor gene is associated with familial erythrocytosis.
Arcasoy MO; Karayal AF; Segal HM; Sinning JG; Forget BG
Blood; 2002 Apr; 99(8):3066-9. PubMed ID: 11929803
[TBL] [Abstract][Full Text] [Related]
18. Familial polycythemia due to truncations of the erythropoietin receptor.
Forget BG; Degan BA; Arcasoy MO
Trans Am Clin Climatol Assoc; 2000; 111():38-44; discussion 44-5. PubMed ID: 10881330
[TBL] [Abstract][Full Text] [Related]
19. Expansion of EPOR-negative macrophages besides erythroblasts by elevated EPOR signaling in erythrocytosis mouse models.
Wang J; Hayashi Y; Yokota A; Xu Z; Zhang Y; Huang R; Yan X; Liu H; Ma L; Azam M; Bridges JP; Cancelas JA; Kalfa TA; An X; Xiao Z; Huang G
Haematologica; 2018 Jan; 103(1):40-50. PubMed ID: 29051279
[TBL] [Abstract][Full Text] [Related]
20. Primary familial polycythaemia associated with a novel point mutation in the erythropoietin receptor.
Furukawa T; Narita M; Sakaue M; Otsuka T; Kuroha T; Masuko M; Azegami T; Kishi K; Takahashi M; Utsumi J; Koike T; Aizawa Y
Br J Haematol; 1997 Oct; 99(1):222-7. PubMed ID: 9359528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
